Z Stock Recent News

Seattle, WA, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SEATTLE, August 21, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare Collaborative™ (QLHC), today announced the first patient has been dosed in their clinical trial evaluating Atossa's proprietary (Z)-endoxifen in combination with abemaciclib (VERZENIO®), a cyclin-dependent kinase (CDK) 4/6 inhibitor marketed by Eli Lilly and Company, as a neoadjuvant treatment in high-risk women with newly diagnosed Estrogen Receptor positive (ER+) / Human Epidermal Growth Factor Receptor 2 negative (HER2-) breast cancer. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in oncology with a focus on breast cancer.

SEATTLE, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare Collaborative™ (QLHC), today announced the first patient has been dosed in their clinical trial evaluating Atossa's proprietary (Z)-endoxifen in combination with abemaciclib (VERZENIO®), a cyclin-dependent kinase (CDK) 4/6 inhibitor marketed by Eli Lilly and Company, as a neoadjuvant treatment in high-risk women with newly diagnosed Estrogen Receptor positive (ER+) / Human Epidermal Growth Factor Receptor 2 negative (HER2-) breast cancer. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in oncology with a focus on breast cancer.

Shares of Zillow (Z) have begun to rise as the company posted its latest quarterly results, beating analyst estimates on both the top and bottom line while also naming a new CEO, Jeremy Waxman, who previously served as the company's COO. Zillow Group CEO Jeremy Wacksman joins Market Domination to give insight into his new position and what lies ahead for the company.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

A broader market selloff, like the one seen in the S&P 500 earlier this week, triggered by the unwinding of a so-called ‘carry trade' started in Japan, tends to bring down essentially all stocks regardless of their fundamental picture. Now trading at only 75% of their 52-week high, shares of Zillow Group Inc. NASDAQ: Z have become a worthy name for investors to consider during these selloffs.

The online real estate leader beat top-line estimates in its second-quarter report. The company made more progress to GAAP profitability.

Zillow Group (Z) shares jumped as the real estate services company reported better-than-expected results for the second quarter and named a new chief executive officer.

Zillow (NASDAQ:Z) shares surged almost 20% on Thursday as the real estate marketplace posted better-than-expected financial results for the second quarter and unveiled its new chief executive. Chief operating officer Jeremy Wacksman has been promoted to CEO and been appointed to the company's board of directors, the company said.

Zillow's (ZG) second-quarter 2024 results benefit from healthy growth in residential and rental segments.

Zillow Group CEO Jeremy Wacksman joins ‘Squawk on the Street' to discuss whether the company can continue to outpace the residential real estate industry, what a housing super-app does, and why now was the time for a leadership change.